热门资讯> 正文
Sarepta Therapeutics再融资7亿美元可转换票据
2025-08-21 19:15
- Sarepta治疗(SRPT) 0
- 纳比特(NA) 0
- 盛大科技(SDA) 0
- Sarepta Therapeutics (NASDAQ:SRPT) reached agreements with select noteholders to exchange about $700M of its 1.25% convertible notes due 2027 for $602M of new 4.875% notes due 2030, up to 6.7M shares of common stock, and $123M in cash.
- The new notes carry a conversion rate of 16.6667 shares per $1,000 principal amount of the notes—equivalent to a conversion price of $60 per share, a 191% premium to the stock’s Aug. 20 closing price of $20.58. Sarepta also signed a deal with J. Wood Capital Advisors for a private placement of up to 1.4M shares.
- SRPT -2.33%.
More on Sarepta Therapeutics
- Sarepta Therapeutics: Beaten Down, But Not Out
- Sarepta: Despite Restructuring, Downgrading To Sell After Latest Developments
- Strategic Restructure and ELEVIDYS Label Update Call
- Sarepta sells Arrowhead stock, activates $100M milestone payment
- Biotech sector slips amid reported return of ousted FDA official
推荐文章
港股周报丨阿里重磅利好！周内暴涨14%；北水单周净买入港股608亿港元环比骤增8成
一周财经日历 | 万众瞩目！9月美联储利率决议来袭；三只港股新股即将上市
美股机会日报 | 金价年内或触及3800美元？国际大行集体唱多黄金！超微电脑涨超5%
能否赶上美联储下周议息会议？美参院就米兰理事提名表决时间定了
港股异动 | 重磅利好！阿里涨近7%，百度涨超6%
华盛早报 | 创近4年新高！阿里大涨8%；外资热情势不可挡！大摩：超九成美国投资者愿加仓中国资产
美股机会日报 | 美国8月CPI符合预期，初请失业金人数创近四年新高！“网红股”Opendoor股价大涨超30%
万亿南向“活水”疯狂抢筹！重仓阿里巴巴逾1200亿港元，如何抄“聪明钱”的作业？
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
